
Novelna is a biotechnology and AI company focused on transforming cancer diagnostics through early disease detection. Their AI-enabled platform integrates advanced protein measurement with artificial intelligence to improve biomarker discovery for cancers and other diseases. The company aims to make early disease detection accessible, accurate, and affordable globally, balancing financial success with positive societal impact. Novelna develops innovative diagnostic technologies and pipelines to address the lack of effective screening tests for many diseases, particularly cancers, thereby improving health outcomes worldwide.

Novelna is a biotechnology and AI company focused on transforming cancer diagnostics through early disease detection. Their AI-enabled platform integrates advanced protein measurement with artificial intelligence to improve biomarker discovery for cancers and other diseases. The company aims to make early disease detection accessible, accurate, and affordable globally, balancing financial success with positive societal impact. Novelna develops innovative diagnostic technologies and pipelines to address the lack of effective screening tests for many diseases, particularly cancers, thereby improving health outcomes worldwide.